Navigation Links
Bard® Magnum® Instrument and Needle

ProductsBard® Magnum® Instrument and Needle
Company C. R. Bard, Inc.
Item Bard® Magnum® Instrument and Needle
Features 
  • Powerful dual spring system for consistent, excellent core samples, rapid-fire action.
  • Small size, lightweight for single person operation.
  • One hand activation to provide easy access to the tissue sample.
  • Dual penetration depths for flexibility and convenience (22mm or 15mm).
Description Every Bard® Biopsy Instrument and Needle is specially designed to help you achieve one important goal: a large quality, reliable core sample. All needles are engineered for exceptional performance, featuring ultra-sharp tips and polished surfaces for smooth entry and exit. A broad selection of biopsy systems and needle sizes assures an ideal match with procedural needs and personal preferences.
Info C. R. Bard, Inc.
Customer Service: (800) 367-2273
Web site: http://www.crbard.com

Related medicine products :

1. Bard® PerFix® Plug
2. Bard® Composix® E/X Mesh
3. Bard® Channel Drain
4. Bard® 4-Channel Urodynamic System
5. Bard® Magnum® Instrument Needles
6. Bard® Monopty® Instrument
7. Bard® MaxCore™ Instrument and Needle
8. Microsurgical Instrument Tray
9. Instrument Tray
10. Mayo Instrument Stand
11. Mobile Instrument Stand
... is the primary active hormone synthesized within ... [1]. T4 is synthesized via a series ... the follicular cells, (ii) iodination of tyrosine ... formation of 3-monoiodotyrosine and 3,5-diiodotyrosine (MIT and ...
... growth factor binding protein-3 (IGFBP-3) is the main ... serum, as a component of the ~150 kDa ... molecule of IGF-I or IGF-II and ALS, allowing ... of the IGFs. The molar concentration of IGFBP-3 ...
... Growth hormone (GH) is a monomeric protein ... anterior pituitary gland. GH is released from ... pulsatile manner under the regulatory control of ... [1]. The timing and frequency of GH ...
... I (IGF-I or somatomedin C) is a 7.6 ... acts as a potent mitogen of cellular proliferation, ... receptors. In the circulation, IGF-I is bound to ... actions of IGF-I by modulating the interaction of ...
Medicine Products:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... ... ... Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and Mental ... exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took place ... BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive an ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
Breaking Medicine Technology: